There has been a significant shift in the fundamentals for Moderna Inc (NASDAQ:MRNA)
Moderna Inc (NASDAQ:MRNA) shares traded -12.25% lower at $24.43 on Wall Street last session. MRNA stock price is now -17.77% away from the 50-day moving average and -51.95% away from the 200-day moving average. The market capitalization of the company currently stands at $9.45B. With the price target of $40, Citigroup recently initiated with Neutral […]
Do you still think Moderna Inc (NASDAQ:MRNA) is worth a look?
Stocks of Moderna Inc (NASDAQ:MRNA) traded higher last session on Wall Street, down -0.62% to $27.22. MRNA stock price is now -11.30% away from the 50-day moving average and -49.74% away from the 200-day moving average. The market capitalization of the company currently stands at $10.50B. With the price target of $40, Citigroup recently initiated […]
An overview of Moderna Inc’s (MRNA) institutional holdings
In Tuesday’s Wall Street session, Moderna Inc (NASDAQ:MRNA) shares traded at $25.74, up 2.43% from the previous session. MRNA stock price is now -16.79% away from the 50-day moving average and -53.63% away from the 200-day moving average. The market capitalization of the company currently stands at $9.93B. With the price target of $40, Citigroup […]
There has been a significant shift in the fundamentals for Moderna Inc (NASDAQ:MRNA)
Moderna Inc (NASDAQ:MRNA) shares traded 6.94% higher at $26.20 on Wall Street last session. MRNA stock price is now -18.34% away from the 50-day moving average and -55.06% away from the 200-day moving average. The market capitalization of the company currently stands at $10.11B. With the price target of $40, Citigroup recently initiated with Neutral […]
An overview of Moderna Inc’s (MRNA) institutional holdings
The price of Moderna Inc (NASDAQ:MRNA) shares last traded on Wall Street fell -2.41% to $25.11. MRNA stock price is now -25.54% away from the 50-day moving average and -58.86% away from the 200-day moving average. The market capitalization of the company currently stands at $9.69B. With the price target of $40, Citigroup recently initiated […]
Before Investing In Moderna Inc (NASDAQ:MRNA), Here Are Some Things To Consider
The stock of Moderna Inc (NASDAQ:MRNA) last traded at $27.16, down -4.20% from the previous session. MRNA stock price is now -21.25% away from the 50-day moving average and -56.73% away from the 200-day moving average. The market capitalization of the company currently stands at $10.48B. With the price target of $40, Citigroup recently initiated […]
There’s Something Awry at Moderna Inc (NASDAQ:MRNA) Since Share Price Gets Ahead of Fundamentals
The stock of Moderna Inc (NASDAQ:MRNA) last traded at $33.85, down -0.94% from the previous session. MRNA stock price is now -3.09% away from the 50-day moving average and -48.53% away from the 200-day moving average. The market capitalization of the company currently stands at $13.06B. With the price target of $40, Citigroup recently initiated […]
There’s Something Awry at Moderna Inc (NASDAQ:MRNA) Since Share Price Gets Ahead of Fundamentals
Moderna Inc (NASDAQ:MRNA) shares traded -1.45% lower at $33.32 on Wall Street last session. MRNA stock price is now -6.87% away from the 50-day moving average and -51.04% away from the 200-day moving average. The market capitalization of the company currently stands at $12.86B. With the price target of $40, Citigroup recently initiated with Neutral […]
Does Moderna Inc (NASDAQ:MRNA) have deteriorating prospects?
Moderna Inc (NASDAQ:MRNA) shares traded -6.12% lower at $33.76 on Wall Street last session. MRNA stock price is now -7.70% away from the 50-day moving average and -52.95% away from the 200-day moving average. The market capitalization of the company currently stands at $13.03B. With the price target reduced from $111 to $45, Barclays Downgraded […]
Does Moderna Inc (NASDAQ:MRNA) warrant a purchase right now? What to Consider Before Making a Decision
Moderna Inc (NASDAQ:MRNA) shares traded 15.94% higher at $35.21 on Wall Street last session. MRNA stock price is now -4.73% away from the 50-day moving average and -52.29% away from the 200-day moving average. The market capitalization of the company currently stands at $13.58B. With the price target reduced from $111 to $45, Barclays Downgraded […]
